📰 Bioengineer Working News

Bioengineer Working News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Bioengineer Working. Real-time updates on events, politics, business and more.

Israel's Sol-Gel signs Canadian licensing deal for Twyneo, Epsolay (NASDAQ:SLGL)

June 6, 2023

Israel's Sol-Gel (SLGL) has signed an exclusive licensing deal with Searchlight Pharma for the Canadian commercialization rights to its dermatology products Twyneo and Eposolay.

Antibiotics In Laboratory Screen Showing Virus Analysis Software User Interface Research Scientist Female Research Scientist Bioengineer Working Personal Computer

Source: seekingalpha.com

Pfizer: New Potential Billion-Dollar Drugs Under Development (NYSE:PFE)

July 10, 2022

Pfizer has a pipeline with more than 90 drugs in development. Pfizer is developing two drugs capable of generating more than a billion sales. Competition is fierce but Pfizer is in the race.

United States Sarepta Exondys Centers For Disease Screen Showing Virus Analysis Software User Interface Antibiotics In Laboratory Research Scientist

Source: seekingalpha.com

EOM Pharmaceutical Files For $25 Million IPO Uplisting To Nasdaq (EOM)

June 28, 2022

EOM Pharmaceutical has filed to raise $25m in an IPO, primarily for product development and to repay an outstanding note. Click here for details on the EOM IPO.

Minas Gerais Endevica Bio Irachb Taraporewala Moses Goldberger Gilead Sciences Screen Showing Virus Analysis Software User Interface

Source: seekingalpha.com

Eye drug developer Belite Bio stock soars 160% following $36M IPO

April 29, 2022

Eye drug developer Belite Bio (BLTE) stock soared 160% following its $36M initial public offering. Shares of BLTE opened at $12.50 after pricing at $6 per American Depositary Share

United States Belite Bio Lin Bioscience Donovan Jones Belite Bio Antibiotics In Laboratory Research Scientist

Source: seekingalpha.com